Related Experiment Video
Updated: Nov 28, 2025

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
Published on: May 17, 2015
Hypoperfusion is a potential inducer of immunosuppressive network in Alzheimer's disease
1Department of Neurology, Institute of Clinical Medicine, University of Eastern Finland, P.O. Box 1627, FI-70211 Kuopio, Finland.
Insights
Hypoxia in Alzheimer's disease (AD) drives immunosuppression through mechanisms like inflammation and altered immune cell function, supporting the vascular hypothesis of AD. This research explores these links to understand AD pathogenesis.
Area of Science:
- Neuroimmunology
- Vascular Biology
- Neurodegenerative Diseases
Background:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder causing irreversible cognitive decline.
- The etiology of late-onset AD remains largely unknown, despite over a century of research.
- Emerging evidence supports the vascular hypothesis, linking brain hypoperfusion to AD pathology.
Purpose of the Study:
- To investigate the role of hypoperfusion and hypoxia in AD pathogenesis.
- To elucidate the mechanisms by which hypoxia-inducible factor-1α (HIF-1α) modulates immune responses in the context of AD.
- To explore the association between hypoxia-induced immunosuppression and AD-related immunological changes.
Main Methods:
- Review and examination of existing literature on hypoxia, inflammation, and AD.
- Analysis of neuroimaging studies revealing brain hypoperfusion in AD-vulnerable regions.
- Detailed examination of immunological mechanisms, including HIF-1α signaling, immune cell phenotypes, and exosome secretion.
Main Results:
- Hypoperfusion and hypoxia are implicated in AD pathology, potentially explaining beta-amyloid deposition and inflammation.
- Hypoxia-inducible factor-1α (HIF-1α) stimulates inflammatory responses and promotes immunosuppression via multiple pathways.
- AD pathology exhibits enhanced immunosuppression, characterized by M2 microglia/macrophage shifts and increased regulatory T cells (Tregs).
Conclusions:
- Hypoxia-induced immunosuppression shares common mechanisms with AD pathogenesis.
- These immunological findings provide strong support for the vascular hypothesis of Alzheimer's disease.
- Understanding these links is crucial for developing novel therapeutic strategies for AD.
Abstract:
Alzheimer's disease (AD) is a progressive neurodegenerative disease which causes a non-reversible cognitive impairment and dementia. The primary cause of late-onset AD remains unknown although its pathology was discovered over a century ago. Recently, the vascular hypothesis of AD has received backing from evidence emerging from neuroimaging studies which have revealed the presence of a significant hypoperfusion in the brain regions vulnerable to AD pathology. In fact, hypoxia can explain many of the pathological changes evident in AD pathology, e.g. the deposition of β-amyloid plaques and chronic low-grade inflammation. Hypoxia-inducible factor-1α (HIF-1α) stimulates inflammatory responses and modulates both innate and adaptive immunity. It is known that hypoxia-induced inflammation evokes compensatory anti-inflammatory response involving tissue-resident microglia/macrophages and infiltrated immune cells. Hypoxia/HIF-1α induce immunosuppression by (i) increasing the expression of immunosuppressive genes, (ii) stimulating adenosinergic signaling, (iii) enhancing aerobic glycolysis, i.e. lactate production, and (iv) augmenting the secretion of immunosuppressive exosomes. Interestingly, it seems that these common mechanisms are also involved in the pathogenesis of AD. In AD pathology, an enhanced immunosuppression appears, e.g. as a shift in microglia/macrophage phenotypes towards the anti-inflammatory M2 phenotype and an increase in the numbers of regulatory T cells (Treg). The augmented anti-inflammatory capacity promotes the resolution of acute inflammation but persistent inflammation has crucial effects not only on immune cells but also harmful responses to the homeostasis of AD brain. I will examine in detail the mechanisms of the hypoperfusion/hypoxia-induced immunosuppressive state in general and especially, in its association with AD pathogenesis. These immunological observations support the vascular hypothesis of AD pathology.
More Related Videos
09:33Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
Published on: December 26, 2016
10:19Neurodegeneration in an Animal Model of Chronic Amyloid-beta Oligomer Infusion Is Counteracted by Antibody Treatment Infused with Osmotic Pumps
Published on: August 14, 2016
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cell-mediated Immune Responses